Epilepsy Society welcomes new labeling on sodium valproate
Epilepsy Society has welcomed a Department of Health initiative to introduce better labeling on the packaging of the anti-epileptic drug sodium valproate, warning women and healthcare professionals of the risks associated with the medication.
Minimising risk from flashing lights
Epilepsy Society has reminded people whose seizures are triggered by flashing lights to take extra care as the winter season of parties and celebrations begins. Epilepsy Society’s consultant neurologist Dr Fergus Rugg-Gunn talks about ways to minimise your risk if you have photosensitive epilepsy.
Anti-Psychotic drugs and epilepsy
Epilepsy Society has stressed that anti-psychotic drugs should only ever be prescribed for people with epilepsy where essential. The charity's Medical Director Professor Ley Sander said this was particularly important when prescribing for those who also had learning difficulties.
Generic lamotrigine equivalent to branded version, study shows
Epilepsy Society has welcomed the findings of a new study which shows that the performance of the generic version of lamotrigine is equivalent to the original branded version of the the anti-epileptic medication.
Doctors in new warning about epilepsy drug valproate
Results of a Europe-wide review of the epilepsy drug valproate, known to cause birth defects, has resulted in the Government sending strengthened warnings to all prescribing doctors and pharmacists.
Brain's natural valium could stop seizures, scientists say
Researchers at Stanford University School of Medicine have found that a naturally occurring protein secreted only in discrete areas of the mammalian brain may act as a Valium-like brake on certain types of epileptic seizures.